Komparativna analiza financijskih izvještaja farmaceutske industrije u Republici Hrvatskoj

master's thesis

• Title (english): Comparative analysis of financial statements of pharmaceutical industry in the Republic of Croatia
• Author: Karmen Abramović
• Mentor: Lajoš Žager (mentor)
• Committee member: Sanja Sever Mališ (predsjednik povjerenstva)
• Committee member: Nikolina Dečman (član povjerenstva)
• Granter: University of Zagreb; Faculty of Economics and Business; Zagreb
• Defense date and country: 2015-07-21, Croatia
• Scientific / art field, discipline and subdiscipline: SOCIAL SCIENCES; Economics

Abstract

Osnovni cilj u ovom radu bio je utvrditi razinu uspješnosti poslovanja odabranih poduzeća farmaceutske industrije u Republici Hrvatskoj uzimajući u obzir uvjete gospodarske krize i razdoblje nepovoljnih kretanja na tržištu.
Horizontalnom i vertikalnom analizom analizirani su financijski izvještaji hrvatskih proizvođača lijekova te je napravljena njihova međusobna usporedba prema vrijednosti i strukturi imovine i obveza, vrijednosti ukupnog prihoda i ostvarenoj neto dobiti. Nadalje, provedena je usporedba financijskih pokazatelja poduzeća kojom se željelo ukazati na trenutno stanje, potencijal i trendove rasta farmaceutske industrije u Hrvatskoj.
Komparativnom analizom došlo se do zaključka da je većina financijskih pokazatelja hrvatskih proizvođača lijekova zadovoljavajuća. Dobri pokazatelji likvidnosti i zaduženosti sugeriraju na povoljan trend širenja poslovanja u budućnosti, dok manji problemi kod pokazatelja aktivnosti upućuju na ulaganje dodatnih napora kod smanjenja trajanja naplate potraživanja.
S obzirom na brzorastuću konkurenciju potrebna su konstantna ulaganja u istraživanje i razvoj, kvalitetu i inovativnost proizvoda, kako bi se održao korak s istom, za što hrvatski proizvođači lijekova prema analizi financijskih izvještaja imaju potencijala i povoljnu perspektivu.

Abstract (english)

The main objective of this paper was to determine the level of business performance of selected enterprises of the pharmaceutical industry in the Republic of Croatia in conditions of economic crisis and the period of adverse market movements.
After the horizontal and vertical analysis of financial statements was done, a comparison of enterprises was made based on the value of their total assets, the structure of assets and liabilities, the value of their total revenue and their net profit. Furthermore, a comparison of financial indicators was made to indicate the current status, potential, and growth of the pharmaceutical industry in Croatia.
By comparative analysis it was concluded that most of the financial indicators of Croatian drug manufacturers is satisfying. Good indicators of liquidity and indebtedness suggest a favorable trend in business expansion in the future, while minor problems with activity indicators point to further efforts in reducing the duration of the collection of receivables.
Due to the fast-growing competition, constant investments in research and development, quality and innovation of products are required, for which Croatian manufacturers of drugs according to the analysis of financial statements have potential and favorable perspective.

• Keywords: analiza financijskih izvještaja; financijski pokazatelji; farmaceutska industrija; Pliva Hrvatska; Belupo; Jadran-Galenski laboratorij
• Keywords (english): analysis of financial statements; financial indicators; pharmaceutical industry; Pliva Hrvatska; Belupo; Jadran-Galenski laboratorij
• Language: croatian
• URN:NBN: urn:nbn:hr:148:981883
• Study programme: Title: Business Economics; Study programme type: university; Study level: graduate; Academic / professional title: magistar/magistra ekonomije (magistar/magistra ekonomije)
• Type of resource: Text
• File origin: Born digital
• Access conditions: Access restricted to students and staff of home institution
• Created on: 2016-10-11 17:45:18